India News: Exit Exam for DPharm Students Deferred Indefinitely by NBEMS
Impact of NBEMS Decision on DPharm Students
NAGPUR: In a relief for diploma in pharmacy (DPharm) students across the country, the Pharmacy Council of India (PCI) has allowed registration and issuance of licenses to the 2022-23 batch after their exit exam, scheduled for October 2024, was deferred indefinitely by the National Board of Examinations in Medical Sciences (NBEMS).
NBEMS postponed the DPharm Exit Examination (DPEE), comprising three papers, urging students to keep checking its website for updates. However, it did not provide any specific reason for the deferment, leaving the student community in a lurch.
In the absence of registration certificates and licenses, the graduating batch of 2024 has been unable to work as pharmacists or start their own businesses. On December 31, PCI notified students that the exam had been deferred indefinitely and announced that it would allow registration and licensing for one year for all students. PCI had previously prohibited students from renewing their licenses without passing the exit exam.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.